Amit Etkin's most recent trade in Alto Neuroscience Inc. was a trade of 6,227 Common Stock done at an average price of $19.7 . Disclosure was reported to the exchange on March 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.69 per share. | 01 Mar 2026 | 6,227 | 1,233,949 | - | 19.7 | 122,610 | Common Stock |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 306,000 | 306,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 247,290 | 247,290 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 247,290 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 223,000 | 223,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 223,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 215,000 | 215,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 215,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2025 | 34,620 | 34,620 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jul 2025 | 34,620 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 215,000 | 215,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 223,000 | 223,000 | - | - | Employee Stock Option (Right to Buy) | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,711 | 1,240,176 | - | 0 | Common Stock | |
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 25,000 | 0 | - | - | Series B Preferred Stock | ||
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | 06 Feb 2024 | 11,777 | 1,202,340 | - | - | Common Stock | ||
| Alto Neuroscience Inc | Amit Etkin | Director, PRESIDENT AND CEO | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 06 Feb 2024 | 3,125 | 1,205,465 | - | 16 | 50,000 | Common Stock |